Skip to main content

Advertisement

Log in

Current insights in Whipple’s disease

  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

Therapy for Whipple’s disease should be continued for a minimum of 1 year, and the regimen should include an agent or agents that achieve acceptable concentrations in the central nervous system, given the likelihood of recurrence at this site. Clinical follow-up of proven cases of Whipple’s disease should be conducted for a minimum of 10 years after discontinuation of therapy, given the potential for late relapses. Polymerase chain reaction analysis is preferred rather than endoscopy when evaluating for disease recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Durand DV, Lecomte C, Cathebras P, et al.: Whipple’s disease: clinical review of 52 cases. Medicine 1997, 6:170–184.Important review of clinical manifestations.

    Article  Google Scholar 

  2. Dobbins WO: Whipple’s Disease. Springfield, IL: Charles C Thomas, 1987.

    Google Scholar 

  3. Marth T: Whipple’s disease. In Principles and Practice of Infectious Diseases, edn 5. Edited by Mandell GI, Dolin R, Bennett JE. Philadelphia: Churchill Livingstone; 1999:1170–1174.

    Google Scholar 

  4. Misbah SA, Ozols B, Franks A, et al.: Whipple’s disease without malabsorption: new atypical features. Q J Med 1997, 90:765–772.

    CAS  Google Scholar 

  5. Ehrbar H,Bauerfiend P, Dutly H, et al.: PCR positive tests for Tropheryma whippelei in patients without Whipple’s disease. Lancet 1999, 353:2214.

    Article  PubMed  CAS  Google Scholar 

  6. Singer R: Diagnosis and treatment of Whipple’s disease [review]. Drugs1998, 55:699–704.

    Article  PubMed  CAS  Google Scholar 

  7. Flemming JL, Wiesner RH, Shorter RG: Whipple’s disease: clinical, biochemical and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc 1988, 63:539–551.

    Google Scholar 

  8. Ratnaike RN: Whipple’s disease. Postgrad Med J 2000, 76:760–766.

    Article  PubMed  CAS  Google Scholar 

  9. Ramzan NN, Loftus E, Burgart LJ, et al.: Diagnosis and monitoring of Whipple’s disease by polymerase chain reaction. Ann Intern Med 1997, 126:520–527. This article compares the use of PCR with conventional histopathologic review to diagnose and monitor WD with gastrointestinal and CNS involvement.

    PubMed  CAS  Google Scholar 

  10. Keinath RD, Merrell DE, Vlietstra R, et al.: Antibiotic treatment and relapse in Whipple’s disease. Longterm follow-up of 88 patients. Gastroenterology 1985, 88:1867–1873.

    PubMed  CAS  Google Scholar 

  11. Schneider T, Stallmack A, von Herbay G, et al.: Successful treatment of refractory Whipple’s disease with adjunctive interferon gamma treatment [abstract]. Gastroenterology 1997, 112:1085. This article contains a review of symptoms of WD with cerebral involvement in patients receiving TMP/SMX.s

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flemmer, M.C., Flenner, R.W. Current insights in Whipple’s disease. Curr Treat Options Gastro 6, 13–16 (2003). https://doi.org/10.1007/s11938-003-0028-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-003-0028-3

Keywords

Navigation